J-Y Cahn

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

Veronika Bachanová, D I Marks, M-J Zhang et al. · Leukemia · 2013 · 135 citations · Full text

Medicine, Immunology, Oncology +12

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

Pierre Tiberghien, J-Y Cahn, M Vowels et al. · Bone Marrow Transplantation · 1998 · 129 citations

Life Sciences, Hematology, Oncology +15

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

Mohamad Mohty, Myriam Labopin, Marie-Lorraine Balère et al. · Leukemia · 2010 · 87 citations

Life Sciences, Hematology, Immunology +17

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

Michael R. Bishop, Brent R. Logan, Sharavi Gandham et al. · Bone Marrow Transplantation · 2007 · 53 citations · Full text

Medicine, Hematology, Oncology +17

Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis

Séverine Lissandre, J-O Bay, J-Y Cahn et al. · Bone Marrow Transplantation · 2010 · 22 citations

Medicine, Hematology, Immunology +14